Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Assessing the pros and cons of zero based budgeting can guide your financial planning. Discover what works best for your situation.
28,655 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Stocks rise on May 7, 2026 as AI-driven demand powers gains in the S&P 500 and SPY. Traders weigh earnings catalysts ...
The Senate committee advanced the crypto market structure bill, signaling momentum but not guaranteed passage. Analys...
As market rates swing and volatility persists, a 4.75% yield from an active covered-call ETF is reshaping retirement ...
As Trump claims credit for the market surge, data shows Nvidia-led momentum dominates the gains and market breadth re...
Pi Network's PI token faces renewed volatility this week, dipping to a fresh weekly low near $0.12 as traders weigh k...
RH is poised to release Q1 results after the bell, with investors watching for margins, international exposure, and t...
XRP rebounded from a key support area but hits a major hurdle around $1.30. Traders eye moving averages and a potenti...
As markets rally, Americans save less than the maximum 401(k) contribution. The gap creates lifetime shortfalls that ...
A veteran CIO warns that even stellar AI earnings may not keep momentum, suggesting the market is testing whether thi...
Oil futures climbed after the U.S. Treasury canceled a license that allowed limited Iranian oil sales, triggering a f...
U.S. households are trimming credit-card balances as total debt hovers near $1.25 trillion, signaling a shift in cons...